CA3140565C — Preparation containing tetracyclic compound at high dose
Assigned to Chugai Pharmaceutical Co Ltd · Expires 2022-10-11 · 4y expired
What this patent protects
An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethy1-6,6- dimethy1-8-(4-morpholin-4-yl-piperidin-1-y1)-11-oxo-6,11- dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compo…
USPTO Abstract
An improved solubility of a pharmaceutical composition or formulation containing a large amount of 9-ethy1-6,6- dimethy1-8-(4-morpholin-4-yl-piperidin-1-y1)-11-oxo-6,11- dihydro-5H-benzo[b]carbazole-3-carbonitrile or a salt thereof can be achieved by forming granules of the compound or salt thereof and allowing the granules to be present together with a disintegrating agent. <DIG>
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.